Gsk GSK
NYSE GSK
$50.12 +1.99 (+4.12%)
As of: Sep 14, 2026 · 2:09 PM EDT

Gsk (GSK) Change in Acquisitions & Divestments (2009 - 2021)

Gsk (GSK) posted Change in Acquisitions & Divestments of $24.3 million for Q4 2021, down 2.24% quarter-over-quarter from $24.8 million in Q1 2021.

Analysis

Gsk (GSK) Change in Acquisitions & Divestments (2009 - 2021) Analysis & Trends

Gsk (GSK) has 6 years of Change in Acquisitions & Divestments data on file, last reported at $24.3 million in Q4 2021.

  • For the quarter ending Q4 2021, Change in Acquisitions & Divestments changed N/A year-over-year to $24.3 million; the trailing twelve-month figure through Dec 2021 stood at $625.2 million (changed N/A YoY), and the FY2021 full-year result was $24.8 million, changed N/A from the prior year.
  • Change in Acquisitions & Divestments was $24.3 million for Q4 2021 at Gsk, down from $24.8 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $24.8 million in Q1 2021 to a low of $24.3 million in Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Asml Holding 618.15 Bn 602.17 Bn 5.90 Bn
2 Hsbc Holdings 361.30 Bn 361.30 Bn -
3 General Electric 329.60 Bn 320.25 Bn 6.95 Bn
4 Astrazeneca 253.73 Bn 248.45 Bn 12.86 Bn
5 Citigroup 227.27 Bn -2,075.03 Bn 24.75 Bn
6 Bhp 215.97 Bn 197.42 Bn -
7 Rio Tinto 203.71 Bn 199.33 Bn -
8 Diageo 197.34 Bn 195.30 Bn -
9 Unilever 139.06 Bn 132.03 Bn -
10 Gsk 101.54 Bn 101.54 Bn 15.97 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 24.26 Mn
Mar 31, 2021 24.82 Mn
Dec 31, 2013 569.91 Mn
Mar 31, 2013 6.22 Mn
Dec 31, 2012 232.85 Mn
Mar 31, 2012 -39.28 Mn
Dec 31, 2011 -22.00 Mn
Mar 31, 2011 64.05 Mn
Dec 31, 2010 52.14 Mn
Sep 30, 2010 3.10 Mn
Mar 31, 2010 43.70 Mn
Dec 31, 2009 4.90 Mn
Sep 30, 2009 42.66 Mn
Mar 31, 2009 33.05 Mn